Eric d'Esparbes
2020 - BIORA THERAPEUTICS
In 2020, Eric d'Esparbes earned a total compensation of $2.3M as Executive Vice President, Chief Financial Officer and Principal Financial Officer at BIORA THERAPEUTICS.
Compensation breakdown
Non-Equity Incentive Plan | $135,000 |
---|---|
Option Awards | $964,988 |
Salary | $450,000 |
Stock Awards | $769,204 |
Other | $17,670 |
Total | $2,336,862 |
d'Esparbes received $965K in option awards, accounting for 41% of the total pay in 2020.
d'Esparbes also received $135K in non-equity incentive plan, $450K in salary, $769.2K in stock awards and $17.7K in other compensation.
Rankings
In 2020, Eric d'Esparbes' compensation ranked 4,845th out of 13,090 executives tracked by ExecPay. In other words, d'Esparbes earned more than 63.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,845 | 63rd |
Manufacturing | 1,965 | 65th |
Chemicals And Allied Products | 774 | 66th |
Drugs | 667 | 66th |
Pharmaceutical Preparations | 505 | 65th |
d'Esparbes' colleagues
We found two more compensation records of executives who worked with Eric d'Esparbes at BIORA THERAPEUTICS in 2020.
News
BIORA THERAPEUTICS CEO Adi Mohanty's 2023 pay slips 11% to $3.1M
April 24, 2024
BIORA THERAPEUTICS CEO Adi Mohanty's 2022 pay falls 65% to $3.5M
April 27, 2023
BIORA THERAPEUTICS CEO Adi Mohanty receives $10M in 2021
April 28, 2022
BIORA THERAPEUTICS CEO Harry Stylli's 2020 pay jumps 1,357% to $5.8M
April 15, 2021
Innoviva CEO Michael Aguiar's 2018 pay slips 11% to $3.7M
March 13, 2019